Stock market's 'sell in May and go away' rule could miss summer rally

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Nigeria News News

Investors who 'sell in May and go away' this year could miss a big summer rally in the stock market, Bank of America says

references the fact that the stock market has historically performed weak during the six-month period of May through October.

The fact that the average and median gains for the stock market are not negative during the"sell in May and go away" time frame, the strategy"leaves much to be desired," Suttmeier said. "May can be a weak month for the S&P 500, but if you 'sell in May and go away' you could miss a Summer rally," Suttmeier said.

That contrasts with the months of May and September, which have delivered average returns of -0.04% and -1.16%, respectively.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Love how we go from inflation, depression & interest rate hikes to summer rallies MAGA

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stock market outlook: Rally coming amid strong earnings, weaker dollarThe stock market is poised to rally thanks to strong earnings and a weakening dollar, Deutsche Bank's chief US equity strategist says BidenInflation
Source: BusinessInsider - 🏆 729. / 51 Read more »

U.S. stock futures near highs of the year as earnings season eyedThe S&P 500 is in line to begin Monday near the top of the 3,800 to 4,200 range within which it has vacillated for about five months.
Source: MarketWatch - 🏆 3. / 97 Read more »

Amneal Pharmaceuticals’ stock soars 14% premarket after company offers upbeat Q1 guidanceAmneal Pharmaceuticals Inc.’s stock soared 14% in premarket trade Monday, after the generics and specialty pharmaceuticals company offered first-quarter...
Source: MarketWatch - 🏆 3. / 97 Read more »